Beneficial response to rituximab in refractory Felty Syndrome.
Nicole
N
Weinreb
Arthur
A
Rabinowitz
Paul F
PF
Dellaripa
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D003937:Diagnosis, Differential; D005258:Felty Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008875:Middle Aged; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab